ctrl K

Watchlist Price Alert

Aeglea BioTherapeutics In... (AGLE)

NASDAQ: AGLE · Real-Time Price · USD

12.01

0.75 (6.66%)

At close: Nov 27, 2023, 9:00 PM

Aeglea BioTherapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	2.33M	18.74M	n/a	n/a	3.89M	5.21M	4.63M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	2.33M	18.74M	n/a	n/a	3.89M	5.21M	4.63M
Operating Income	-84.78M	-65.65M	-81.48M	-80.33M	-45.46M	-27.68M	-21.91M
Interest Income	837K	111K	593K	2.14M	1.17M	482K	244K
Pretax Income	-83.95M	-65.66M	-80.89M	-78.25M	-44.35M	-27.24M	-21.7M
Net Income	-83.81M	-65.8M	-80.3M	-75.69M	-44.35M	-27.24M	-21.7M
Selling & General & Admin	28.53M	27.32M	21.84M	15.73M	12.63M	10.07M	8.39M
Research & Development	58.58M	57.07M	59.64M	64.6M	36.72M	22.82M	18.14M
Other Expenses	-7K	-122K	-5K	-63K	-57K	-42K	-36K
Operating Expenses	87.11M	84.39M	81.48M	80.33M	49.35M	32.88M	26.53M
Interest Expense	837K	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	87.11M	84.39M	81.48M	80.33M	49.35M	32.88M	26.53M
Income Tax Expense	-136K	141K	-593K	-2.56M	-57K	-731K	-244K
Shares Outstanding (Basic)	3.37M	2.63M	2.13M	1.28M	832.9K	605.13K	391.67K
Shares Outstanding (Diluted)	3.37M	2.63M	2.13M	1.28M	832.9K	605.13K	391.67K
EPS (Basic)	-24.86	-25.02	-37.61	-59.23	-53.25	-45.01	-55.4
EPS (Diluted)	-24.86	-25.02	-37.61	-59.23	-53.25	-45.01	-55.4
EBITDA	-84.78M	-65.65M	-80.48M	-80.33M	-44.05M	-27.68M	-21.77M
EBIT	-83.11M	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	1.57M	1.58M	996K	418K	293K	249K	132K